Alumis’ most advanced product candidate, ESK-001, is an oral, highly selective, small molecule, allosteric inhibitor of tyrosine kinase 2 that is currently being evaluated for the treatment of ...

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis Two trials for active psoriatic arthritis (PsA) with one focusing on ...

Meanwhile, following a Mediterranean diet for psoriatic arthritis and psoriasis can also reduce chronic inflammation. Fish ...

Furthermore, 27% of all patients needed assistance with their psoriasis treatment. The authors cited study limitations such ...

If you have eczema you’ll be all too familiar with those cracked, dry, and scaly patches of skin that show up a bright red on ...

Study authors examined the use of artificial intelligence in machine learning models for the assessment of psoriasis severity, as well as identified future research needs.

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update Ended the third quarter with $493.9 million in cash, cash equivalents and short-term marketable ...

Organon (OGN) stock on watch as FDA delays a potential label expansion for its VTAMA cream, impacting 2025 EBITDA margin and ...

Research shows lifestyle changes like diet, exercise, and smoking cessation can assist with improving psoriasis outcomes and ...

She is an internationally recognized expert in psoriasis and has led over 60 clinical trials and observational studies in psoriasis and other skin diseases. She is the Vice-Chair/Chair-Elect of the ...

It can also be used to treat plaque psoriasis and psoriatic arthritis in ... It’s thought that Stelara passes into breast milk in small amounts. If you’re breastfeeding or planning to ...